Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1988 Oct;41(10):1078–1084. doi: 10.1136/jcp.41.10.1078

DNA content and MHC class II antigen expression in malignant melanoma: clinical course.

J Zaloudik 1, M Moore 1, A K Ghosh 1, Z Mechl 1, A Rejthar 1
PMCID: PMC1141691  PMID: 3192729

Abstract

To assess the clinical value of two comparatively new properties (DNA content and MHC class II antigen expression (HLA-DR, DP, DQ) of melanoma cells) which have been independently reported to reflect the outlook for patients with malignant melanoma, we investigated retrospectively 50 stage I nodular melanomas in two comparably homogeneous groups of 23 and 27 patients, the course of whose disease differed at five years. Flow cytometry and immunohistology were used on paraffin wax embedded archival material for the analysis of DNA ploidy and detection of class II antigens, respectively. A close association was found between class II antigen expression, detected by monoclonal antibody CR3/43 (antimonomorphic DR, DP, DQ) present in 23 of 50 (46%) melanomas and unfavourable clinical course (p less than 0.005, by log rank test), but no such association was found for DNA ploidy. It is suggested that immunohistology for MHC class II antigen expression may help to predict the behaviour of nodular melanomas whereas the prognostic value of DNA ploidy is more limited. The finding that class II positive cells are found predominantly in melanomas with a substantially increased risk of metastases has implications both for concepts of tumour heterogeneity and host immunity.

Full text

PDF
1078

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albino A. P., Houghton A. N. Cell surface antigens of melanocytes and melanoma. Cancer Surv. 1985;4(1):185–211. [PubMed] [Google Scholar]
  2. Albino A. P., Houghton A. N., Eisinger M., Lee J. S., Kantor R. R., Oliff A. I., Old L. J. Class II histocompatibility antigen expression in human melanocytes transformed by Harvey murine sarcoma virus (Ha-MSV) and Kirsten MSV retroviruses. J Exp Med. 1986 Nov 1;164(5):1710–1722. doi: 10.1084/jem.164.5.1710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Albino A. P., Le Strange R., Oliff A. I., Furth M. E., Old L. J. Transforming ras genes from human melanoma: a manifestation of tumour heterogeneity? Nature. 1984 Mar 1;308(5954):69–72. doi: 10.1038/308069a0. [DOI] [PubMed] [Google Scholar]
  4. Anichini A., Castelli C., Sozzi G., Fossati G., Parmiani G. Differential susceptibility to recombinant interferon-gamma-induced HLA-DQ antigen modulation among clones from a human metastatic melanoma. J Immunol. 1988 Jan 1;140(1):183–191. [PubMed] [Google Scholar]
  5. Basham T. Y., Bourgeade M. F., Creasey A. A., Merigan T. C. Interferon increases HLA synthesis in melanoma cells: interferon-resistant and -sensitive cell lines. Proc Natl Acad Sci U S A. 1982 May;79(10):3265–3269. doi: 10.1073/pnas.79.10.3265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bodmer W. F. HLA today. Hum Immunol. 1986 Dec;17(4):490–503. doi: 10.1016/0198-8859(86)90307-1. [DOI] [PubMed] [Google Scholar]
  7. Bodmer W. F. The HLA system: structure and function. J Clin Pathol. 1987 Sep;40(9):948–958. doi: 10.1136/jcp.40.9.948. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bröcker E. B., Suter L., Brüggen J., Ruiter D. J., Macher E., Sorg C. Phenotypic dynamics of tumor progression in human malignant melanoma. Int J Cancer. 1985 Jul 15;36(1):29–35. doi: 10.1002/ijc.2910360106. [DOI] [PubMed] [Google Scholar]
  9. Bröcker E. B., Suter L., Sorg C. HLA-DR antigen expression in primary melanomas of the skin. J Invest Dermatol. 1984 Mar;82(3):244–247. doi: 10.1111/1523-1747.ep12260181. [DOI] [PubMed] [Google Scholar]
  10. Büchner T., Hiddemann W., Wörmann B., Kleinemeier B., Schumann J., Göhde W., Ritter J., Müller K. M., von Bassewitz D. B., Roessner A. Differential pattern of DNA-aneuploidy in human malignancies. Pathol Res Pract. 1985 Jan;179(3):310–317. doi: 10.1016/s0344-0338(85)80140-0. [DOI] [PubMed] [Google Scholar]
  11. Cillo C., Mach J. P., Schreyer M., Carrel S. Antigenic heterogeneity of clones and subclones from human melanoma cell lines demonstrated by a panel of monoclonal antibodies and flow microfluorometry analysis. Int J Cancer. 1984 Jul 15;34(1):11–20. doi: 10.1002/ijc.2910340104. [DOI] [PubMed] [Google Scholar]
  12. Cordell J. L., Falini B., Erber W. N., Ghosh A. K., Abdulaziz Z., MacDonald S., Pulford K. A., Stein H., Mason D. Y. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem. 1984 Feb;32(2):219–229. doi: 10.1177/32.2.6198355. [DOI] [PubMed] [Google Scholar]
  13. Friedlander M. L., Hedley D. W., Taylor I. W. Clinical and biological significance of aneuploidy in human tumours. J Clin Pathol. 1984 Sep;37(9):961–974. doi: 10.1136/jcp.37.9.961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ghosh A. K., Moore M., Street A. J., Howat J. M., Schofield P. F. Expression of HLA-D sub-region products on human colorectal carcinoma. Int J Cancer. 1986 Oct 15;38(4):459–464. doi: 10.1002/ijc.2910380402. [DOI] [PubMed] [Google Scholar]
  15. Groenewegen G., de Ley M., Jeunhomme G. M., Buurman W. A. Supernatants of human leukocytes contain mediator, different from interferon gamma, which induces expression of MHC class II antigens. J Exp Med. 1986 Jul 1;164(1):131–143. doi: 10.1084/jem.164.1.131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hedley D. W., Friedlander M. L., Taylor I. W., Rugg C. A., Musgrove E. A. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem. 1983 Nov;31(11):1333–1335. doi: 10.1177/31.11.6619538. [DOI] [PubMed] [Google Scholar]
  17. Herlyn M., Guerry D., Koprowski H. Recombinant gamma-interferon induces changes in expression and shedding of antigens associated with normal human melanocytes, nevus cells, and primary and metastatic melanoma cells. J Immunol. 1985 Jun;134(6):4226–4230. [PubMed] [Google Scholar]
  18. Holzmann B., Bröcker E. B., Lehmann J. M., Ruiter D. J., Sorg C., Riethmüller G., Johnson J. P. Tumor progression in human malignant melanoma: five stages defined by their antigenic phenotypes. Int J Cancer. 1987 Apr 15;39(4):466–471. doi: 10.1002/ijc.2910390410. [DOI] [PubMed] [Google Scholar]
  19. Houghton A. N., Eisinger M., Albino A. P., Cairncross J. G., Old L. J. Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets. J Exp Med. 1982 Dec 1;156(6):1755–1766. doi: 10.1084/jem.156.6.1755. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Houghton A. N., Real F. X., Davis L. J., Cordon-Cardo C., Old L. J. Phenotypic heterogeneity of melanoma. Relation to the differentiation program of melanoma cells. J Exp Med. 1987 Mar 1;165(3):812–829. doi: 10.1084/jem.165.3.812. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Houghton A. N., Thomson T. M., Gross D., Oettgen H. F., Old L. J. Surface antigens of melanoma and melanocytes. Specificity of induction of Ia antigens by human gamma-interferon. J Exp Med. 1984 Jul 1;160(1):255–269. doi: 10.1084/jem.160.1.255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Jones D. J., Moore M., Schofield P. F. Prognostic significance of DNA ploidy in colorectal cancer: a prospective flow cytometric study. Br J Surg. 1988 Jan;75(1):28–33. doi: 10.1002/bjs.1800750111. [DOI] [PubMed] [Google Scholar]
  23. Kornstein M. J., Brooks J. S., Elder D. E. Immunoperoxidase localization of lymphocyte subsets in the host response to melanoma and nevi. Cancer Res. 1983 Jun;43(6):2749–2753. [PubMed] [Google Scholar]
  24. Laerum O. D., Farsund T. Clinical application of flow cytometry: a review. Cytometry. 1981 Jul;2(1):1–13. doi: 10.1002/cyto.990020102. [DOI] [PubMed] [Google Scholar]
  25. Merkel D. E., Dressler L. G., McGuire W. L. Flow cytometry, cellular DNA content, and prognosis in human malignancy. J Clin Oncol. 1987 Oct;5(10):1690–1703. doi: 10.1200/JCO.1987.5.10.1690. [DOI] [PubMed] [Google Scholar]
  26. Natali P. G., Bigotti A., Cavaliere R., Nicotra M. R., Ferrone S. Phenotyping of lesions of melanocyte origin with monoclonal antibodies to melanoma-associated antigens and to HLA antigens. J Natl Cancer Inst. 1984 Jul;73(1):13–24. [PubMed] [Google Scholar]
  27. Natali P. G., Cordiali-Fei P., Cavaliere R., Di Filippo F., Quaranta V., Pellegrino M. A., Ferrone S. Ia-like antigens on freshly explanted human melanoma. Clin Immunol Immunopathol. 1981 May;19(2):250–259. doi: 10.1016/0090-1229(81)90067-2. [DOI] [PubMed] [Google Scholar]
  28. Natali P. G., De Martino C., Quaranta V., Bigotti A., Pellegrino M. A., Ferrone S. Changes in Ia-like antigen expression on malignant human cells. Immunogenetics. 1981;12(3-4):409–413. doi: 10.1007/BF01561680. [DOI] [PubMed] [Google Scholar]
  29. Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer. 1977 Jan;35(1):1–39. doi: 10.1038/bjc.1977.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Pfizenmaier K., Scheurich P., Schlüter C., Krönke M. Tumor necrosis factor enhances HLA-A,B,C and HLA-DR gene expression in human tumor cells. J Immunol. 1987 Feb 1;138(3):975–980. [PubMed] [Google Scholar]
  31. Pollack M. S., Chin-Louie J., Moshief R. D. Functional characteristics and differential expression of class II DR, DS, and SB antigens on human melanoma cell lines. Hum Immunol. 1984 Feb;9(2):75–87. doi: 10.1016/0198-8859(84)90030-2. [DOI] [PubMed] [Google Scholar]
  32. Ramila G., Studer S., Kennedy M., Sklenar I., Erb P. Evaluation of accessory cell heterogeneity. I. Differential accessory cell requirement for T helper cell activation and for T-B cooperation. Eur J Immunol. 1985 Jan;15(1):1–6. doi: 10.1002/eji.1830150102. [DOI] [PubMed] [Google Scholar]
  33. Real F. X., Houghton A. N., Albino A. P., Cordon-Cardo C., Melamed M. R., Oettgen H. F., Old L. J. Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues. Cancer Res. 1985 Sep;45(9):4401–4411. [PubMed] [Google Scholar]
  34. Sunderland C. A., Naiem M., Mason D. Y., Redman C. W., Stirrat G. M. The expression of major histocompatibility antigens by human chorionic villi. J Reprod Immunol. 1981 Dec;3(6):323–331. doi: 10.1016/0165-0378(81)90048-6. [DOI] [PubMed] [Google Scholar]
  35. Søndergaard K., Larsen J. K., Møller U., Christensen I. J., Hou-Jensen K. DNA ploidy-characteristics of human malignant melanoma analysed by flow cytometry and compared with histology and clinical course. Virchows Arch B Cell Pathol Incl Mol Pathol. 1983;42(1):43–52. doi: 10.1007/BF02890369. [DOI] [PubMed] [Google Scholar]
  36. Taramelli D., Fossati G., Mazzocchi A., Delia D., Ferrone S., Parmiani G. Classes I and II HLA and melanoma-associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesions. Cancer Res. 1986 Jan;46(1):433–439. [PubMed] [Google Scholar]
  37. Tsujisaki M., Igarashi M., Sakaguchi K., Eisinger M., Herlyn M., Ferrone S. Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes. J Immunol. 1987 Feb 15;138(4):1310–1316. [PubMed] [Google Scholar]
  38. Wass J., Zbroja R. A., Young G. A., Vincent P. C., Joyce R. M., Croaker G. Malignant melanoma: analysis by DNA flow cytometry. Pathology. 1985 Jul;17(3):475–480. doi: 10.3109/00313028509105504. [DOI] [PubMed] [Google Scholar]
  39. Wilson B. S., Indiveri F., Pellegrino M. A., Ferrone S. DR (Ia-like) antigens on human melanoma cells. Serological detection and immunochemical characterization. J Exp Med. 1979 Mar 1;149(3):658–668. doi: 10.1084/jem.149.3.658. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. von Roenn J. H., Kheir S. M., Wolter J. M., Coon J. S. Significance of DNA abnormalities in primary malignant melanoma and nevi, a retrospective flow cytometric study. Cancer Res. 1986 Jun;46(6):3192–3195. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES